OSTX OS Therapies
- 4.180
- +0.180+4.50%
OS Therapies News
OS Therapies | SC 13G: Statement of acquisition of beneficial ownership by individuals
OS Therapies | 8-K: Current report
OS Therapies | 8-K: OS Therapies Reports Second Quarter 2024 Financial Results
OS Therapies | 10-Q: Quarterly report
OS Therapies | 4: Statement of changes in beneficial ownership of securities-Director Ciccio John
OS Therapies | 4: Statement of changes in beneficial ownership of securities-Director Search Theodore F.
OS Therapies | 424B4: Prospectus
OS Therapies | 3: Initial statement of beneficial ownership of securities-Director Search Theodore F.
OS Therapies | 3: Initial statement of beneficial ownership of securities-Officer Romness Paul A.
OS Therapies | 3: Initial statement of beneficial ownership of securities-Officer PETIT ROBERT
OS Therapies | 3: Initial statement of beneficial ownership of securities-Director GODDARD COLIN
OS Therapies | 3: Initial statement of beneficial ownership of securities-Director Ciccio John
OS Therapies | 3: Initial statement of beneficial ownership of securities-Director Borg Joacim
OS Therapies | 3: Initial statement of beneficial ownership of securities-Officer Acevedo Christopher P.
OS Therapies | EFFECT: Others
OS Therapies | CERT: Others
OS Therapies | 8-A12B: Registration of a class of securities on a national securities exchange
OS Therapies | CORRESP: CORRESP
OS Therapies | CORRESP: CORRESP
OS Therapies | CORRESP: CORRESP
Analysis
Price Target
No Data
